OptimizeRx
OPRX
56 hedge funds and large institutions have $106M invested in OptimizeRx in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 6 closing their positions.
283% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 6
84% more capital invested
Capital invested by funds: $57.4M → $106M (+$48.1M)
58% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 12
40% more funds holding
Funds holding: 40 → 56 (+16)
10.28% more ownership
Funds ownership: 37.3% → 47.58% (+10%)
66% less call options, than puts
Call options by funds: $299K | Put options by funds: $872K
Top Buyers
| 1 |
BlackRock
New York
|
+$7.83M |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
+$4.66M |
| 3 |
Calamos Advisors
Naperville,
Illinois
|
+$3.61M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.29M |
| 5 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
+$1.94M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$979K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$633K |
| 3 |
JP Morgan Chase
New York
|
-$494K |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$364K |
| 5 |
Goldman Sachs
New York
|
-$346K |
OPRX Hedge Fund Activity: Q2 2019 in Review
56 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2019, worth a combined $106M — up 84% from $57.4M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new OPRX positions and 6 closed out — a net gain of 17 holders — while 19 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $7.83M. The largest seller was Millennium Management, cutting an estimated $979K.
- 56 institutional investors held OptimizeRx (OPRX) as of Q2 2019, up from 40 in Q1 2019.
- Funds reported $106M of OptimizeRx stock for Q2 2019, up 84% quarter-over-quarter.
- 23 funds opened new OptimizeRx positions in Q2 2019 and 6 closed out, a net change of +17 holders.
- The largest OptimizeRx buyer in Q2 2019 was BlackRock, an estimated $7.83M added.
- The largest OptimizeRx seller in Q2 2019 was Millennium Management, an estimated $979K sold.
Based on aggregated 13F filings for Q2 2019.